Cullin-RING (CRL) and RING1-IBR-RING2 (RBR) are two distinct types of ubiquitin ligases. In this issue, Scott et al. show that CRLs activate the RBR enzyme ARIH1 to initiate ubiquitin chains on CRL substrates, thereby marking an unexpected and important advance in our understanding of both enzymes.
Cullin-RING ubiquitin ligases comprise a family of hundreds of intracellular enzymes that catalyze attachment of ubiquitin to substrate proteins, resulting in a change in the stability, localization, assembly, or activity of the substrate. Collectively, these enzymes have an enormous impact on eukaryotic biology, and mutations in individual CRLs have been linked to numerous human diseases. Tremendous progress has been made in understanding the mechanism of action of CRLs, but Scott et al. reveal that these fascinating enzymes appear to have a secret life that up to now has escaped scrutiny.
To understand this latest advance, a bit more context is needed. CRLs are modular and feature a variable substrate receptor (SR) that is recruited to one end of the cullin subunit that serves as the enzyme's backbone. The other end of the cullin binds the RING protein Rbx1/Roc1/ Hrt1, which recruits and activates a ubiquitin-conjugating (E2) enzyme thioesterified with ubiquitin (UBE2D1-4Ub or UBE2R1/2Ub) (Figure 1 ). CRLs are normally inactive, but conjugation of the ubiquitin-like protein Nedd8 to cullin causes a conformational change that switches them on (Duda et al., 2008) . Once activated, successive rounds of E2Ub recruitment and Ub discharge occur rapidly, resulting in the initiation and elongation of a chain of ubiquitins on substrate bound to the CRL (Pierce et al., 2009) , which marks it for degradation by the proteasome. This tidy picture emerged from nearly two decades of extensive biochemistry and structural biology on these fascinating enzymes. However, just when you think you are beginning to understand how things work, nature throws you a curveball.
Although appealing, there were some problems with the simple picture depicted above. For example, work on SCF (CRL1) and UBE2R1/2 emphasized that these enzymes are built to assemble polyubiquitin chains (Pierce et al., 2009 ). Thus, it was hard to understand why other CRLs that use the same Rbx1 subunit preferentially monoubiquitinate their substrates (Jin et al., 2012; Wang et al., 2006) . More recently, there was the report that Nedd8-conjugated CRL5 binds to and activates ubiquitin discharge from ARIH2, a member of the RBR family of ubiquitin ligases (Kelsall et al., 2013) . It was puzzling why an RBR would sequester the 'business end' of a CRL to become activated, to the potential detriment of CRL substrates.
In this issue, the report by Scott et al. (2016) elegantly resolves these conundrums in one fell swoop. Through a comprehensive set of biochemical and cellular experiments, these authors fashion an important revision to our understanding of how CRLs work. The picture that emerges is that an ARIH protein collaborates with a CRL to transfer the first ubiquitin to the CRL substrate (ARIH1 for CRLs1-3 and ARIH2 for CRL5), after which ARIH gives way to UBE2R1/2, which builds the ubiquitin chain. ARIH normally exists in an autoinhibited state in which the catalytic cysteine in its RING2 domain is concealed (Kelsall et al., 2013) . Upon binding to a Nedd8-conjugated CRL (N8-CRL), this residue becomes exposed (Kelsall et al., 2013) , resulting in the transfer of ubiquitin from the charged, ARIH-specific E2, UBE2L3Ub, to the ARIH1 active site cysteine ( Figure 1 ). From there, ubiquitin is discharged onto a lysine of substrate bound to the SR of N8-CRL. What is particularly striking is that, whereas ARIH1 is exceptionally speedy at transferring the first ubiquitin to substrate, it is far slower at elongating a chain. Thus, its proclivity is to monoubiquitinate substrates. The authors propose that substrate polyubiquitination by human CRLs involves teamwork, with ARIH initiating the chains and UBE2R1/2 extending them (Figure 1) .
Chain priming and extending by distinct E2s was originally shown with anaphasepromoting complex (Rodrigo-Brenni and Morgan, 2007) and has also been shown for SCF, in which case the E2 UBE2D3 primes substrates with a single ubiquitin, which is extended by UBE2R1/2 (Wu et al., 2010) . However, the work by Scott et al. is the first clear example where two distinct E3s work in an interdependent manner to polyubiquitinate substrate. It fundamentally changes how we think about CRL function.
This study raises multiple questions and will animate much future work. In our view, the most critical issue is the degree to which CRL reactions are normally primed by ARIH1/2. A major conclusion of Scott et al. is that an ARIH-to-UBE2R1/2 handoff (which they dub ''team-tagging'') is a general feature of CRL ubiquitination reactions. The authors show that this can happen in reactions with purified proteins and that cells depleted of ARIH1 accumulate CRL substrates. However, there are caveats to both results. The chain extension rates that they observe in the presence of ARIH1 and UBE2R1 are slow compared to other reports (Pierce et al., 2009) , and it is difficult to exclude the possibility that accumulation of unmodified ARIH1 substrates in depleted cells might have indirect effects on CRL function.
It is interesting to speculate why the ARIH-dependent mechanism evolved. Whereas budding and fission yeasts both contain ARIH homologs (K. Hofmann, personal communication), they do not appear to be essential for CRL activity. In addition, Scott et al. do not link CRL4A or CRL4B to an ARIH. Does some other RBR protein collaborate with CRL4 enzymes, or can they get by without one? We suggest two divergent explanations. First, perhaps the great expansion of CRLs in metazoans has necessitated equipping them with additional widgets to cope with their broader range of substrates. Certain CRLs or even substrates themselves may have sequences that favor the recruitment of ARIH1/2 to speed up the chain initiation step. This could explain why Scott et al. find that, whereas the SCF FBXL3 substrate CRY1 shows exquisite ARIH1 dependence, UBE2D2 is better at ubiquitinating the SCF FBXW11 substrate IkB. It could also account for why the authors' analysis of ARIH1-associated proteins reveals a substantial bias for CUL3 and its SRs, even though CUL1 is 3-fold more abundant (Bennett et al., 2010) . More extensive evaluation of different CRL:substrate pairs should reveal which combinations benefit most from ARIH activity and why. The second possibility is that perhaps ARIH proteins have evolved primarily to equip CRLs with the capacity to preferentially monoubiquitinate substrates to control their function without specifying their degradation. This could greatly expand the regulatory capacity of these enzymes. This need not be mutually exclusive to the ''teamtagging'' idea espoused by the authors, but it does raise the question of why some reactions would progress to polyubiquitination.
To gain a deeper understanding of this novel mechanism, it will be important to determine the concentration of ARIH1/2 and dynamics of CRL interactions in light of the kinetic properties of ARIH-catalyzed monoubiquitination. This should reveal whether there is sufficient ARIH1 to sustain chain initiation for all CRLdependent ubiquitination events.
Lastly, it should be noted that, in addition to ARIH1/2, UBE2D1-4, and UBE2R1/2, many additional proteins congregate to the same region on CRLs, and it is curious how CRLs manage to avoid gridlock. Covalent modifications, co-localization, or cooperative assembly may favor recruitment of particular subsets of these proteins to different CRLs. Alternatively, ARIH1/2 dissociation from CRLs may be facilitated by UBE2R1/2 binding, similar to how the SR exchange factor CAND1 promotes dissociation of CRL SRs (Pierce et al., 2013) . Finally, if the rate of protein association and dissociation from the CRLs is far more rapid than the rate of ubiquitin transfer to CRL-bound substrate, the traffic jam may be inconsequential. As is always the case with an important finding, this discovery closes one door while opening several others. Ubiquitin transfer from a ubiquitin-conjugating (E2) enzyme thioesterified with ubiquitin (UBE2L3Ub) to a RING1-IBR-RING2 (RBR) ubiquitin ligase, ARIH, is stimulated in the presence of a Nedd8-conjugated Cullin-RING ubiquitin ligease (N8-CRL). The ARIHUb conjugate bound to N8-CRL is poised to transfer its ubiquitin to substrate bound to the substrate receptor (SR), presumably followed by the dissociation of spent ARIH from the complex. Subsequent ubiquitin transfer events are handled by the E2 UBE2R1/2 and result in ubiquitin chain elongation.
